Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells

被引：0
|
作者：
Patricia Midori Murobushi Ozawa
Faris Alkhilaiwi
Iglenir João Cavalli
Danielle Malheiros
Enilze Maria de Souza Fonseca Ribeiro
Luciane Regina Cavalli
机构：
[1] Georgetown University Medical Center,Department of Oncology, Lombardi Comprehensive Cancer Center
[2] Federal University of Paraná,Department of Genetics
[3] King Abdulaziz University,Faculty of Pharmacy
来源：
Breast Cancer Research and Treatment | 2018年 / 172卷
关键词：
TNBC; Exosomes; Proliferation; Drug resistance; Gene expression; miRNA expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：713 / 723
页数：10
相关论文
共 50 条
  • [1] Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
    Murobushi Ozawa, Patricia Midori
    Alkhilaiwi, Faris
    Cavalli, Iglenir Joao
    Malheiros, Danielle
    de Souza Fonseca Ribeiro, Enilze Maria
    Cavalli, Luciane Regina
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (03) : 713 - 723
  • [2] Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
    Yi, Yong Weon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [3] Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
    Pederson, Petra J.
    Liang, Huiyun
    Filonov, Daria
    Mooberry, Susan L.
    CANCERS, 2021, 13 (11)
  • [4] SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
    Geng, Wenwen
    Cao, Meiling
    Dong, Ke
    An, Junhua
    Gao, Haidong
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)
  • [5] Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer
    Nishida-Aoki, Nao
    Izumi, Yoshihiro
    Takeda, Hiroaki
    Takahashi, Masatomo
    Ochiya, Takahiro
    Bamba, Takeshi
    METABOLITES, 2020, 10 (02)
  • [6] Proteomic analysis of talazoparib resistance in triple-negative breast cancer cells
    Guney Eskiler, Gamze
    Yanar, Sevinc
    Akpinar, Gurler
    Kasap, Murat
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (03)
  • [7] Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF
    Yang, Kaihua
    Yao, Yufeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 5858 - 5868
  • [8] PSMB5 is associated with proliferation and drug resistance in triple-negative breast cancer
    Wei, Wensong
    Zou, Yufeng
    Jiang, Qihua
    Zhou, Zhibin
    Ding, Haolong
    Yan, Liping
    Yang, Shixin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (01): : 102 - 108
  • [9] TGF-β induced reprogramming and drug resistance in triple-negative breast cells
    Wu, Guoyu
    Li, Yuchao
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [10] TGF-β induced reprogramming and drug resistance in triple-negative breast cells
    Guoyu Wu
    Yuchao Li
    BMC Pharmacology and Toxicology, 23
12345